US 12,491,173 B2 · Metabolism-improving agent comprising rare fatty acid

Abstract

The invention provides a metabolism improving agent containing a rare fatty acid such as hydroxylated fatty acid, oxo fatty acid and the like, and further, food, pharmaceutical product and the like containing the metabolism improving agent.

Claims18

Dependent claims

A method for treating hyperlipidemia comprising administering to a patient an effective amount of a fatty acid selected from the group consisting of 15-hydroxy-cis-11-eicosenoic acid, 15-hydroxy-cis-5,cis-8,cis-11-eicosatrienoic acid, 15-oxo-cis-11-eicosenoic acid, and 15-oxo-cis-5,cis-8,cis-11-eicosatrienoic acid.

Dependencies are inferred from the claim text.

Facts

Application

17/175,186Filed 12 Feb 2021 · division

Priority

JP 2014-01187124 Jan 2014

Published

US 2021/0236448 A15 Aug 2021

Granted

9 Dec 2025

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 31/202
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having three or more double…
A23L 33/12
Fatty acids or derivatives thereof; Fats or oils: fatty acids or derivatives thereof
A61K 31/20
Carboxylic acids, e.g. valproic acid: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
A61K 31/201
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having one or two double bonds,…

Family

PCT/JP2015/051843Parent of this division · filed 23 Jan 2015

Application16/710,302Parent of this division · filed 11 Dec 2019

US 10,548,868 B2Parent of this division · filed 4 Feb 2020

US 2021/0236448 A1Pre-grant publication · published 5 Aug 2021

US 10,952,983 B2Parent of this division

Application15/113,654Parent of this division

US 2017/0007564 A1Published application

US 2020/0101036 A1Published application

US 12,491,173 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Claims18

Dependent claims

Dependencies are inferred from the claim text.

Facts

Application

17/175,186Filed 12 Feb 2021 · division

Priority

JP 2014-01187124 Jan 2014

Published

US 2021/0236448 A15 Aug 2021

Granted

9 Dec 2025

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 31/202
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having three or more double…
A23L 33/12
Fatty acids or derivatives thereof; Fats or oils: fatty acids or derivatives thereof
A61K 31/20
Carboxylic acids, e.g. valproic acid: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
A61K 31/201
Having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids: having one or two double bonds,…

Family

PCT/JP2015/051843Parent of this division · filed 23 Jan 2015

Application16/710,302Parent of this division · filed 11 Dec 2019

US 10,548,868 B2Parent of this division · filed 4 Feb 2020

US 2021/0236448 A1Pre-grant publication · published 5 Aug 2021

US 10,952,983 B2Parent of this division

Application15/113,654Parent of this division

US 2017/0007564 A1Published application

US 2020/0101036 A1Published application

US 12,491,173 B2This patent

From the US filing history. Foreign family members aren’t listed.

Metabolism-improving agent comprising rare fatty acid

Life of this patent

Abstract

Claims18

Metabolism-improving agent comprising rare fatty acid

Life of this patent

Abstract

Claims18